AKT1 and idiopathic pulmonary fibrosis: The network interactions show stable “network responses” and more effective multi-component activity than a single substance.96 Illustrations ofFigures 1,2, and6 explore TGF-β1, MMP9, MMP2, EGFR, AKT1, SRC, and TNF-α as core targets in treating IPF.